Clinical trials
Phase 1/2 Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Recruiting | 11 |
| Terminated | 10 |
| Withdrawn | 4 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 6 |
| Incyte Corporation | 5 |
| Bristol-Myers Squibb | 3 |
| Fred Hutchinson Cancer Center | 3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| John Mascarenhas | 2 |
| Kartos Therapeutics, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Ronald Hoffman | 2 |
| S*BIO | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 65 |
| Myeloproliferative Disorders | 29 |
| Myelodysplastic Syndromes | 23 |
| Leukemia, Myeloid, Acute | 21 |
| Polycythemia Vera | 21 |
| Thrombocythemia, Essential | 19 |
| Leukemia | 17 |
| Lymphoma | 13 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 13 |
| Leukemia, Myelomonocytic, Chronic | 12 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.